Skip to main content

Table 1 Association between symptoms and other patient characteristics with the odds of having undiagnosed COPD (v. no COPD)

From: The diagnostic performance of patient symptoms in screening for COPD

 

OR

95% CI

p-value

Cough

 1 (vs.0)

1.08

0.86–1.36

0.49

 2 (vs.0)

1.38

0.93–2.04

0.11

 3 (vs.0)

1.35

1.09–1.68

0.01

Wheeze

 1 (vs.0)

1.34

1.03–1.73

0.03

 2 (vs.0)

1.74

1.38–2.20

< 0.01

 3 (vs.0)

1.77

0.93–3.38

0.08

Phlegm

 1 (vs.0)

1.21

0.89–1.66

0.23

 2 (vs.0)

1.35

0.77–2.36

0.30

 3 (vs.0)

1.24

0.93–1.65

0.14

Dyspnea

 2 (vs.1)

1.26

1.05–1.50

0.01

 3 (vs.1)

2.05

1.30–3.22

< 0.01

 4 (vs.1)

1.52

0.76–3.03

0.24

 5 (vs.1)

3.35

1.88–5.97

< 0.01

Agea

0.83

0.74-0.94

< 0.01

Female (vs. male)

1.03

0.81–1.30

0.82

BMIa

0.78

0.68-0.89

< 0.01

Caucasian (vs. non-Caucasian)

2.39

1.28–4.48

0.01

Comorbidities

 1 comorbidity (vs. 0)

0.93

0.76–1.14

0.51

 2 comorbidities (vs. 0)

0.75

0.48–1.18

0.21

Smoking between visits (vs. no)

1.16

0.96–1.41

0.13

Smoking Pack-Years

 20–40 (vs. < 20)

2.09

1.53–2.86

< 0.01

  > 40 (vs. < 20)

3.09

2.22–4.32

< 0.01

  1. BMI body mass index, CI confidence interval, OR odds ratio
  2. aVariables were converted to z-scores in the regression model